Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis
Author(s) -
Eduardo AsínPrieto,
Alicia RodríguezGascón,
Iñaki F. Trocóniz,
Amaia Soraluce,
Javier Maynar,
José Ángel SánchezIzquierdo,
Arantxazu Isla
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt304
Subject(s) - piperacillin/tazobactam , piperacillin , medicine , pharmacokinetics , renal replacement therapy , renal function , tazobactam , pharmacodynamics , population , dosing , nonmem , antibacterial agent , pharmacology , anesthesia , intensive care medicine , antibiotics , microbiology and biotechnology , biology , genetics , environmental health , bacteria , pseudomonas aeruginosa
To evaluate the pharmacokinetics of piperacillin/tazobactam in critically ill patients undergoing continuous renal replacement therapy (CRRT) and to assess the success of the therapy against susceptible bacteria.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom